[ Back to EurekAlert! ] Public release date: 14-Aug-2003
[ | E-mail | Share Share ]

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet

Hope for South Africa - at last

This week's editorial urges the South African Government to implement new recommendations to provide antiretroviral treatment to tackle the country's grave HIV/AIDS epidemic.

Three recent developments are detailed that offer some hope to the nearly 5 million South Africans living with HIV/AIDS: the authority of a South African drug company to develop and produce generic antiretrovirals locally and cheaply via voluntary licensing agreements from larger, global drug companies; the signing of an agreement between South African government and the Global Fund to Fight AIDS, Tuberculosis and Malaria to provide a grant of US$41 million over 2 years for treatment and prevention of HIV/AIDS and tuberculosis; and the publishing of a report of the joint Health and Treasury Task Team on Treatment options to supplement comprehensive care for HIV/AIDS in the public health sector was approved at a special Cabinet meeting last week.

The editorial concludes: 'Many South Africans with HIV/AIDS have waited a long time while being repeatedly disappointed by their government leaders, many have died. South Africans are understandably impatient and sceptical. But now there is a real chance to leave the past behind and move swiftly forward to a better future for the people of South Africa. We urge the government to put the recommendations into practice.'

###



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.